CIK: 1536290 - Address: C/O Uniqure, N.V., Amsterdam P7, 11058BP
44 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/28/24 16:17
2/26/24
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,MDS-1776.350-28-6441D
3/9/23 16:58
3/7/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CDOCEO,MDS-5421.390-3-1469D
3/1/23 16:13
2/27/23
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,MDS.m-49320.090-25-5471D
12/13/22 15:34
12/9/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CDOCEO,MDS-14922.440-7-2368D
3/2/22 17:01
2/28/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,MDS-17016.700-10-3361D
1/28/22 16:56
1/26/22
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7OCEO,CFO,S-19718.100-11-4246D
8/20/21 16:14
8/18/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-2828.150-10257D
7/21/21 14:00
7/14/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-2827.770-10258D
6/21/21 10:33
6/16/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-18634.760-5-2259D
5/14/21 11:46
5/12/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-7332.290-2-1264D
4/22/21 09:28
4/14/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-18935.240-5-2266D
3/22/21 13:11
3/17/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-7533.160-2-1272D
3/4/21 13:39
3/2/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7OCEO,CFO,S-18436.940-5-2274D
2/24/21 12:46
2/15/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-13435.380-4-2223D
2/1/21 12:04
1/29/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-24935.580-7-3227D
1/29/21 13:53
1/27/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-1,15436.630-31-12234D
1/29/21 13:48
1/27/21
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-1,15436.630-31-12234D
12/21/20 08:12
12/16/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-60548.410-13-5265D
11/24/20 16:25
11/19/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-51345.180-11-4265D
11/20/20 16:58
11/18/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-45143.690-10-4273D
10/16/20 16:10
10/14/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-18835.860-5-2281D
9/18/20 13:41
9/16/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-30540.660-8-3286D
8/27/20 17:00
8/25/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-1240.27000293D
8/21/20 16:32
8/19/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-16839.110-4-1294D
7/24/20 16:41
7/22/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-23842.310-6-2298D
6/22/20 16:43
6/17/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-49566.040-8-2304D
5/22/20 17:13
5/20/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-45059.940-8-2311D
4/24/20 16:46
4/22/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-53356.870-9-3319D
3/20/20 13:16
3/18/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-23341.480-6-2319D
2/21/20 10:03
2/19/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-48464.560-8-3285D
1/31/20 15:45
1/29/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-3,08460.420-51-16265D
1/29/20 11:24
1/27/20
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-3,31563.900-52-14316D
12/20/19 16:13
12/18/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.d-52970.090-8-2367D
11/22/19 10:12
11/20/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-43053.740-8-2368D
10/25/19 08:38
10/23/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-34643.220-8-2376D
9/20/19 13:49
9/18/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-37847.310-8-2384D
8/23/19 10:43
8/21/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-45256.480-8-2391D
7/19/19 10:37
7/17/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-57271.450-8-2399D
6/20/19 11:03
6/19/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-62077.450-8-2407D
5/17/19 15:48
5/15/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-46758.380-8-2415D
3/15/19 15:15
3/13/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S.m-4,30963.960-67-14423D
1/30/19 19:15
1/28/19
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-60031.420-19-4490D
3/19/18 15:35
3/15/18
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-85121.720-39-8440D
1/5/18 16:40
1/4/18
QUREUniqure N.V.HealthDrugPharmaceutical PreparationsKapusta Matthew CP7DOCEO,CFO,S-43119.870-22-5448D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact